126
Views
1
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

The Neutrophil/Lymphocyte Ratio is an Independent Predictor of All-Cause Mortality in Patients with Idiopathic Hypereosinophilic Syndrome

, & ORCID Icon
Pages 1899-1906 | Published online: 15 Mar 2022

References

  • Ogbogu PU, Rosing DR, Horne MR. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457–475. doi:10.1016/j.iac.2007.07.001
  • Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83(10):2759–2779. doi:10.1182/blood.V83.10.2759.2759
  • Kanno H, Ouchi N, Sato M, et al. Hypereosinophilia with systemic thrombophlebitis. Hum Pathol. 2005;36(5):585–589. doi:10.1016/j.humpath.2005.03.017
  • Barker T, Rogers VE, Henriksen VT, et al. Is there a link between the neutrophil/lymphocyte ratio and venous thromboembolic events after knee arthroplasty? A pilot study. J Orthop Traumatol. 2016;17(2):163–168. doi:10.1007/s10195-015-0378-3
  • Ming L, Jiang Z, Ma J, et al. Platelet-to-lymphocyte ratio, neutrophil/lymphocyte ratio, and platelet indices in patients with acute deep vein thrombosis. Vasa. 2018;47(2):143–147. doi:10.1024/0301-1526/a000683
  • Zhu X, Yao Y, Yao C, et al. Predictive value of lymphocyte to monocyte ratio and monocyte to high-density lipoprotein ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study. J Orthop Surg Res. 2018;13(1):211. doi:10.1186/s13018-018-0910-2
  • Gotlib J. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Am J Hematol. 2015;90(11):1077–1089. doi:10.1002/ajh.24196
  • Lin J, Huang X, Zhou W, et al. Thrombosis in the portal venous system caused by hypereosinophilic syndrome: a case report. Medicine. 2018;97(48):e13425. doi:10.1097/MD.0000000000013425
  • Boussir H, Ghalem A, Ismaili N, et al. Eosinophilic myocarditis and hypereosinophilic syndrome. J Saudi Heart Assoc. 2017;29(3):211–213. doi:10.1016/j.jsha.2016.11.001
  • Fujita K, Ishimaru H, Hatta K, et al. Hypereosinophilic syndrome as a cause of fatal thrombosis: two case reports with histological study. J Thromb Thrombolysis. 2015;40(2):255–259. doi:10.1007/s11239-014-1151-9
  • Zakhama L, Slama I, Boussabah E, et al. Recurrent native and prosthetic mitral valve thrombosis in idiopathic hypereosinophilic syndrome. J Heart Valve Dis. 2014;23(2):168–170.
  • Todd S, Hemmaway C, Nagy Z. Catastrophic thrombosis in idiopathic hypereosinophilic syndrome. Br J Haematol. 2014;165(4):425. doi:10.1111/bjh.12729
  • Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol. 2006;117(6):1292–1302. doi:10.1016/j.jaci.2006.02.042
  • Liu Y, Meng X, Feng J, et al. Hypereosinophilia with concurrent venous thromboembolism: clinical features, potential risk variables, and short-term outcomes in a Chinese cohort. Sci Rep. 2020;10(1):8359. doi:10.1038/s41598-020-65128-4
  • Reau V, Vallee A, Terrier B, et al. Venous thrombosis and predictors of relapse in eosinophil-related diseases. Sci Rep. 2021;11(1):6388. doi:10.1038/s41598-021-85852-9
  • Kushnir M, Cohen HW, Billett HH. Persistent neutrophilia is a marker for an increased risk of venous thrombosis. J Thromb Thrombolysis. 2016;42(4):545–551. doi:10.1007/s11239-016-1398-4
  • Esmaeilzadeh H, Nouri F, Nabavizadeh SH, et al. Can eosinophilia and neutrophil-lymphocyte ratio predict hospitalization in asthma exacerbation? Allergy Asthma Clin Immunol. 2021;17(1):16. doi:10.1186/s13223-021-00512-x
  • Wang BL, Tian L, Gao XH, et al. Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection. Clin Chem Lab Med. 2016;54(12):1963–1969. doi:10.1515/cclm-2015-1191
  • Dolan RD, McSorley ST, Park JH, et al. The prognostic value of systemic inflammation in patients undergoing Surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer. 2018;119(1):40–51. doi:10.1038/s41416-018-0095-9
  • Cannon NA, Meyer J, Iyengar P, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic variables after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol. 2015;10(2):280–285. doi:10.1097/JTO.0000000000000399
  • Marx C, Novotny J, Salbeck D, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134(21):1859–1872. doi:10.1182/blood.2019000518
  • Cugno M, Marzano AV, Lorini M, et al. Enhanced tissue variable expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLoS One. 2014;9(11):e111862. doi:10.1371/journal.pone.0111862
  • Mukai HY, Ninomiya H, Ohtani K, et al. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br J Haematol. 1995;90(4):892–899. doi:10.1111/j.1365-2141.1995.tb05211.x